Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
2005 was a tough year for U.S. biotech financing
As we are still in January, it is appropriate that we continue to review biotech results for 2005 and try to find lessons learned that might help us discern trends for 2006.
Another research tool I have always found useful for this analysis is Burrill & Co.'s financial tracking information on the biotech industry. On......
Full article >>> ded in Burrill's review, as Burrill focuses principally on drugs versus medical devices).
Another interesting trend that Burrill notes is M&A activities. We have all been filing the high profile bidding war in the beginning of 2006 (which actually started in 2005) between Boston Scientific/Abbott Labs and J&J to acquire Guidant; at this writing, it appears that Boston Scientific/Abbott La......
Full article >>> companies, struggling with their pipelines and potential generic intrusion as patents come to an end on key products.
Let's look at Burrill's information on the different channels of biotech financing in 2005:
U.S. biotech financing in 2005 ($millions)
| Type of Financing | 2004 | 2005 | % Change |
| Public Full article >>> n the U.S. Remember that this applies to a little more than the 300 publicly-traded biotech companies in the U.S. VC financing of $3.5 billion in 2005 was down 7 percent. This result is bad news for the 1200+ privately held biotech companies in the U.S. that depend mostly on VC financing. Assuming the number of 1200 companies, the average raise-up per company was less than $3 million in ...... Full article >>> and early stage life science companies such as Renovar, a Wisconsin-based in-vitro diagnostics company. Rosen is also a founder and board member of the Illinois Biotechnology Industry Organization. He can be reached at rosenmichaels@aol.com This article has been syndicated on the Wisconsin Technology Netw...... Full article >>> '"/> Source:wistechnology.com By Michael Rosen 01/30/06 Related biology technology : 1. The tough choices facing health care 2. Venture-backed companies drive job creation, even in tough times 3. Vertical partnering: Street smarts for a tough marketplace 4. The state of global biotech: An Ernst & Young perspective 5. Olympics of biotechnology has international flavor 6. Getting noticed in Genetown: Wisconsin biotech on display 7. Madison biotech NimbleGen files for IPO; one of states best-funded firms 8. Wisconsin biotech firm receives $107K NIH grant 9. Manufacturing partnership will move into biotech and biomedical spaces 10. Wisconsin wont get Georgia biotech without a fight 11. The 10 biggest events shaping biotech in 2006 Post Your Comments: (Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ... (Date:10/10/2017)... Parks Associates announced today that Tom Kerber , Director ... , October 11 in Scottsdale, Arizona . Kerber will ... safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction of ... (Date:10/9/2017)... ... , ... The award-winning American Farmer television series will feature 3 Bar Biologics ... at 8:30aET on RFD-TV. , With global population estimates nearing ten billion people ... to feed a growing nation. At the same time, many of our valuable resources ... (Date:10/7/2017)... ... October 06, 2017 , ... Phase ... metagenome deconvolution product, featuring the first commercially available Hi-C kit. Researchers can ... Hi-C metagenome deconvolution using their own facilities, supplementing the company’s full-service ProxiMeta ... Breaking Biology Technology:[0] Singh Biotechnology Receives Second FDA Orphan Drug Designation for its Novel Single Domain Antibody for the Treatment of Osteosarcoma by Targeting Intracellular STAT3[0] Parks Associates: More Than 26 Million U.S. Broadband Households Will Have Professionally Monitored Security by 2021[0] American Farmer Educates on Recent Advances in Biologics for Food Production[0] Phase Genomics Announces Availability of Kit-based ProxiMeta™ Hi-C Metagenome Deconvolution (Date:10/4/2017)... Oct. 4, 2017 GCE Solutions, a global clinical research organization ... document anonymization solution on October 4, 2017. Shadow is designed to ... comply with policy 0070 of the European Medicines Agency (EMA) in ... ... ... (Date:6/30/2017)... June 30, 2017 Today, American Trucking ... supplier of face and eye tracking software, became ... provider program. "Artificial intelligence and ... to monitor a driver,s attentiveness levels while on ... able to detect fatigue and prevent potential accidents, ... (Date:5/16/2017)... TEANECK, N.J. , May 16, 2017 Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ... Breaking Biology News(10 mins):
|
